2. LBA5-Osimertinib as adjuvant therapy in patients (pts) with stage IB–IIIA EGFR mutation positive (EGFRm) NSCLC after complete tumor resection: ADAURA.2020 ASCO. 3. Osimertinib in Resected EGFR-Mutated Non–Small-Ce...
l Dr.Pasi Janne在ESMO的评价如下: the clinical implications of LUX-Lung 8 study are marginalbenefit of afatinib over erlotinib and increased toxicity. EGFR-inhibitors areused less (if at all) in squamous cell lung cancer...
Update 2025: Management of Non‑Small-Cell Lung Cancer Hyein Jeon Shuai Wang Haiying Cheng Review Open access 25 March 2025 Article: 53 Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published Literature David A. Kaland Graç...
aSchematic of scRNA-seq sample preparation.bUniform manifold approximation and projection (UMAP) plot of all cells colored by GFP+and GFP−samples.cCol1a1expression on UMAP plot of all cells. See Supplementary Fig.1afor identifying the lineages. NK, natural killer cell; Neut, neutrophil; Mac,...
Lung Fact Sheet. Available at: . Accessed September 2023 . 3. Shields MD, et al. Immunotherapy for advanced non-small cell lung cancer: a decade of progress. Am Soc Clin Oncol Educ Book. 2021;41:1-23. 4. Walsh RJ, et al. Resistance to immune checkpoint inhibitors in non-small cell...
Ahn M-J,et al. Datopotamab deruxtecan (Dato-DXd) vs doxetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): results of the randomized phase 3 study TROPION-Lung01. Presented at: ESMO Congress 2023,20-24 October 2023;Madrid, Spain. LBA12. ...
et al. A single-cell atlas of the human healthy airways. Am. J. Respir. Crit. Care Med. 202, 1636–1645 (2020). Article CAS PubMed Google Scholar Sikkema, L. et al. An integrated cell atlas of the human lung in health and disease. Preprint at bioRxiv https://doi.org/10.1101/...
The Difference Between 'i.e.' and 'e.g.' How to Use Em Dashes (—), En Dashes (–) , and Hyphens (-) Why is '-ed' sometimes pronounced at the end of a word? What's the difference between 'fascism' and 'socialism'?
ARTEMIA phase 3 study: A randomized, open-label trial comparing the efficacy and safety of OSE2101 versus docetaxel in HLA-A2 positive patients with metastatic non-small cell lung cancer and secondary resistance to immune checkpoint inhibitors ...
At a glance Drugs Tislelizumab (Primary) ; Docetaxel Indications Non-small cell lung cancer; Squamous cell cancer Focus Registrational; Therapeutic Use Acronyms RATIONALE 303 Sponsors BeiGene Most Recent Events 27 Feb 2024 According to a BeiGene media release, company to receive EMA ...